NEKONAL S A R L has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CT FOR ADDICTION AND MENTAL HEALTH, CELL SIGNALING TECHNOLOGY INC and GODDARD AUDREY.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | United States | 2 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Analysing materials | |
#4 | Medical preparations | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Utku Nalan | 13 |
Publication | Filing date | Title |
---|---|---|
WO2021073877A2 | Anti-tirc7 antigen binding proteins | |
WO2021028579A1 | Method for producing engineered tirc7 specific t-regulatory cells (tregs) | |
WO2018029296A1 | Tirc7 based diagnostic and therapy of solid cancer | |
US2019218307A1 | Tirc7 based diagnostic and therapy of cancer |